Literature DB >> 24587656

Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding.

Yeong Yeh Lee1, Hoi-Poh Tee1, Sanjiv Mahadeva1.   

Abstract

Bacterial infections are common in cirrhotic patients with acute variceal bleeding, occurring in 20% within 48 h. Outcomes including early rebleeding and failure to control bleeding are strongly associated with bacterial infection. However, mortality from variceal bleeding is largely determined by the severity of liver disease. Besides a higher Child-Pugh score, patients with hepatocellular carcinoma are particularly susceptible to infections. Despite several hypotheses that include increased use of instruments, greater risk of aspiration pneumonia and higher bacterial translocation, it remains debatable whether variceal bleeding results in infection or vice versa but studies suggest that antibiotic prophylaxis prior to endoscopy and up to 8 h is useful in reducing bacteremia and spontaneous bacterial peritonitis. Aerobic gram negative bacilli of enteric origin are most commonly isolated from cultures, but more recently, gram positives and quinolone-resistant organisms are increasingly seen, even though their clinical significance is unclear. Fluoroquinolones (including ciprofloxacin and norfloxacin) used for short term (7 d) have the most robust evidence and are recommended in most expert guidelines. Short term intravenous cephalosporin (especially ceftriaxone), given in a hospital setting with prevalent quinolone-resistant organisms, has been shown in studies to be beneficial, particularly in high risk patients with advanced cirrhosis.

Entities:  

Keywords:  Antibiotics; Cirrhosis; Infection; Prophylaxis; Variceal bleeding

Mesh:

Substances:

Year:  2014        PMID: 24587656      PMCID: PMC3930977          DOI: 10.3748/wjg.v20.i7.1790

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  48 in total

1.  Oerskovia xanthineolytica and methicillin-resistant Staphylococcus aureus in a patient with cirrhosis and variceal hemorrhage.

Authors:  A L Truant; V Satishchandran; R Eisenstaedt; P Richman; M M McNeil
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-10       Impact factor: 3.267

2.  Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality.

Authors:  C Homann; K Varming; K Høgåsen; T E Mollnes; N Graudal; A C Thomsen; P Garred
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

Review 3.  Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides.

Authors:  J A Hewett; R A Roth
Journal:  Pharmacol Rev       Date:  1993-12       Impact factor: 25.468

4.  Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis.

Authors:  C Dupeyron; N Mangeney; L Sedrati; B Campillo; P Fouet; G Leluan
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

5.  Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection.

Authors:  A Pauwels; N Mostefa-Kara; B Debenes; E Degoutte; V G Lévy
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

6.  A prospective study of bacterial infections in patients with cirrhosis.

Authors:  W R Caly; E Strauss
Journal:  J Hepatol       Date:  1993-07       Impact factor: 25.083

7.  Systemic antibiotic therapy prevents bacterial infection in cirrhotic patients with gastrointestinal hemorrhage.

Authors:  M Blaise; D Pateron; J C Trinchet; S Levacher; M Beaugrand; J L Pourriat
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

8.  Bacteremia and bacterascites after endoscopic sclerotherapy for bleeding esophageal varices and prevention by intravenous cefotaxime: a randomized trial.

Authors:  W S Selby; I D Norton; C S Pokorny; R A Benn
Journal:  Gastrointest Endosc       Date:  1994 Nov-Dec       Impact factor: 9.427

9.  Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study.

Authors:  B Bernard; J F Cadranel; D Valla; S Escolano; V Jarlier; P Opolon
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

10.  Effect of Helicobacter pylori infection on esophagogastric variceal bleeding in patients with liver cirrhosis and portal hypertension.

Authors:  Yoshihiro Sakamoto; Kazuhiko Oho; Atsushi Toyonaga; Masafumi Kumamoto; Tsuyoshi Haruta; Hiroto Inoue; Keigo Emori; Osamu Tsuruta; Michio Sata
Journal:  J Gastroenterol Hepatol       Date:  2013-09       Impact factor: 4.029

View more
  7 in total

1.  Intestinal barrier dysfunction in cirrhosis: Current concepts in pathophysiology and clinical implications.

Authors:  Georgios I Tsiaoussis; Stelios F Assimakopoulos; Athanassios C Tsamandas; Christos K Triantos; Konstantinos C Thomopoulos
Journal:  World J Hepatol       Date:  2015-08-18

Review 2.  Spontaneous bacterial peritonitis: The clinical challenge of a leaky gut and a cirrhotic liver.

Authors:  Philipp Lutz; Hans Dieter Nischalke; Christian P Strassburg; Ulrich Spengler
Journal:  World J Hepatol       Date:  2015-03-27

Review 3.  Contemporary concepts of the medical therapy of portal hypertension under liver cirrhosis.

Authors:  Dmitry Victorovich Garbuzenko
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

4.  Prognostic factors associated with mortality in patients with gastric fundal variceal bleeding.

Authors:  Keishi Komori; Masaru Kubokawa; Eikichi Ihara; Kazuya Akahoshi; Kazuhiko Nakamura; Kenta Motomura; Akihide Masumoto
Journal:  World J Gastroenterol       Date:  2017-01-21       Impact factor: 5.742

5.  Systemic Inflammatory Response Syndrome in Patients Hospitalized for Acute Decompensation of Cirrhosis.

Authors:  Ariane Borgonovo; Caroline Baldin; Dariana C Maggi; Livia Victor; Emilia T O Bansho; Juliana Piedade; Letícia M Wildner; Lívia Guimarães; Maria L Bazzo; Tamires Rocha; Esther B Dantas-Corrêa; Camila Alcântara; Flávia Fernandes; Janaina L Narciso-Schiavon; Gustavo H S Pereira; Leonardo L Schiavon
Journal:  Can J Gastroenterol Hepatol       Date:  2021-04-25

6.  The Impact of a Multifaceted Pharmacist-Led Antimicrobial Stewardship Program on Antibiotic Use: Evidence From a Quasi-Experimental Study in the Department of Vascular and Interventional Radiology in a Chinese Tertiary Hospital.

Authors:  Jinhui Xu; Jian Huang; YanXia Yu; Dayong Zhou; Ying Wang; Sudong Xue; Erning Shang; Jiantong Sun; Xinyuan Ding; Lu Shi; Lufen Duan; Lian Tang; Qin Zhou; Xin Li
Journal:  Front Pharmacol       Date:  2022-02-28       Impact factor: 5.810

7.  Endotoxin Translocation and Gut Barrier Dysfunction Are Related to Variceal Bleeding in Patients With Liver Cirrhosis.

Authors:  Christos Triantos; Maria Kalafateli; Stelios F Assimakopoulos; Katerina Karaivazoglou; Aikaterini Mantaka; Ioanna Aggeletopoulou; Panagiota I Spantidea; Georgios Tsiaoussis; Maria Rodi; Hariklia Kranidioti; Dimitrios Goukos; Spilios Manolakopoulos; Charalambos Gogos; Dimitrios N Samonakis; Georgios L Daikos; Athanasia Mouzaki; Konstantinos Thomopoulos
Journal:  Front Med (Lausanne)       Date:  2022-03-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.